This chapter explores the different CTLA-4, PD-1 and PD-L1 inhibitors that have been investigated in advanced NSCLC, analyzing the different studies that have been performed, the evidences obtained, and the role in the clinical management of patients.
Immunotherapy / Viscardi, G.; Russo, G. L.; Ferrara, R.; Garassino, M. C.. - (2023), pp. 283-304. [10.1016/B978-0-323-69573-2.00022-X]
Immunotherapy
Ferrara R.;
2023-01-01
Abstract
This chapter explores the different CTLA-4, PD-1 and PD-L1 inhibitors that have been investigated in advanced NSCLC, analyzing the different studies that have been performed, the evidences obtained, and the role in the clinical management of patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
